Find Academic Supervisors

Daniel Finley is a Professor of Cell Biology at Harvard Medical School (HMS), leading the Finley Lab focused on the ubiquitin-proteasome pathway and related regulatory mechanisms. He holds academic appointments within the Department of Cell Biology and sits on the Scientific Advisory Boards of Proteostasis and X-Chem Pharmaceuticals. His research investigates proteasome function, ubiquitin-like proteins, and proteostasis roles in diseases like Alzheimer’s and ALS. Dr. Finley earned his undergraduate degree in biochemistry from Harvard University and a Ph.D. in molecular biology from MIT. After postdoctoral training at MIT, he joined HMS in 1988. His lab explores topics including erythroid proteome remodeling, mitochondrial dysfunction, and neurodegenerative disease mechanisms. Key research areas include: (1) Ubiquitin-proteasome pathway regulation, (2) Proteasome structure/function, (3) Nonproteolytic roles of ubiquitination, and (4) Pathophysiological roles of proteostasis defects in diseases. His work bridges basic cell biology with translational medicine, particularly in neurodegeneration and anemia. Finley has secured NIH funding for projects like 'Regulation of Proteasome Activity' (R35GM145246) and 'Erythrocyte maturation through global proteome remodeling' (R01HL153970). Collaborations with industry and academic partners extend his impact in drug discovery and proteasome-targeted therapies. His lab’s contributions include defining ubiquitin chain editing mechanisms, identifying USP14’s role in mitophagy, and elucidating proteostasis defects in Alzheimer's models. Research tools developed include advanced cryo-EM analyses of proteasomal structures and functional assays for ubiquitin system enzymes.

• Ubiquitin-Proteasome Pathway
• Proteostasis
• Protein Degradation
• +7 more

Anirban Paul is an Associate Professor in the Department of Neuroscience and Experimental Therapeutics at Pennsylvania State University, affiliated with the Penn State Neuroscience Institute. His research focuses on cellular and molecular mechanisms of GABAergic inhibitory circuits, with particular emphasis on interneuron biology and its implications in neurological disorders. Dr. Paul's research spans multiple neuroscience domains, with primary focus on GABAergic inhibitory circuits and interneuron biology. His work investigates how specific neuron subtypes, particularly Chandelier cells and cortical interneurons, contribute to brain function and dysfunction. He has made significant contributions to understanding the role of these cells in schizophrenia, Alzheimer's disease, and other neurological conditions. His research integrates molecular, cellular, and systems-level approaches to uncover fundamental mechanisms of neural circuit assembly, plasticity, and function. Key areas include RNA regulation in neuronal development, transcriptomic subtypes of inhibitory neurons, and cell-type specific vulnerabilities in neurodegenerative diseases. His research portfolio demonstrates consistent productivity with publications spanning from 2003 to 2025, showing an evolving focus from basic molecular neuroscience to translational research in neurological disorders. Recent work emphasizes single-cell analysis techniques and the role of specific interneuron populations in disease mechanisms, particularly in schizophrenia and Alzheimer's disease. His publications appear in high-impact neuroscience journals including Neuron, BMC Biology, and Frontiers in Cellular Neuroscience. Dr. Paul has received the NARSAD Young Investigator Award (2018), recognizing his promising research in neuroscience. His scientific contributions have been supported by multiple competitive grants from prestigious organizations including the National Institute on Aging (NIA) and the Brain and Behavior Research Foundation. He serves as Principal Investigator on multiple active research projects, including two major grants from the National Institute on Aging focused on cell-type specific risk and resilience in Alzheimer's disease and aging (2021-2024 and 2024-2026), as well as previous projects from the Brain and Behavior Research Foundation investigating Chandelier cells in schizophrenia. His research program demonstrates sustained funding and scientific leadership in the field of interneuron biology and its clinical implications.

• Neuroscience
• GABAergic inhibitory circuits
• Interneuron biology
• +5 more

Jennifer L. Clarke is a Professor in the Department of Statistics at the University of Nebraska–Lincoln and Director of the Quantitative Life Science Initiative. She holds leadership roles in enabling big data integration across the University of Nebraska system through collaborative research programs. Her affiliations include the Institute of Agriculture and Natural Resources (IANR) and the College of Agriculture and Natural Resources. Dr. Clarke's research focuses on statistical methodology for high-dimensional data, computational biology, bioinformatics, and bacterial genomics. Her work bridges statistical innovation with applications in oncology, microbiome analysis, and agricultural phenomics. Key areas include predictive modeling, machine learning, and genomic/metagenomic data integration. Her recent publications span cancer biomarker discovery, plant phenotyping methodologies, and microbial community analysis, reflecting her interdisciplinary approach. Articles emphasize translational applications like therapeutic target identification and precision agriculture. Dr. Clarke leads initiatives fostering collaboration between statisticians and domain scientists, including the Quantitative Life Science Initiative and contributions to the Agricultural Genome-to-Phenome Initiative (AG2PI). Her work advances data-driven solutions for healthcare and food security challenges. Notable projects include developing statistical tools for microbiome studies, analyzing root architecture via 3D imaging, and investigating cranberry-derived compounds' cancer-inhibitory mechanisms. Her methodological contributions include hybrid clustering techniques and predictive model validation frameworks.

• Statistical Methodology
• Bioinformatics/Computational Biology
• Data Mining/Machine Learning
• +3 more

Katy D. Heath is a Professor of Plant Biology and Affiliate Professor in Microbiology at the University of Illinois Urbana-Champaign (UIUC). She leads the Plant Biology department and is affiliated with the Carl R. Woese Institute for Genomic Biology. Her research focuses on the evolution of mutualisms, particularly plant-microbe interactions such as legume-rhizobium symbiosis, emphasizing genetic and ecological factors influencing symbiotic stability and adaptation. She investigates how environmental pressures (e.g., global change) shape mutualistic relationships and microbial community dynamics. Education: B.S. (2000) and Ph.D. (2007) from the University of Illinois and University of Minnesota, respectively, followed by postdoctoral work at the University of Toronto (2007–2009). Research Interests: Symbiosis evolution, microbial genetics, plasmid transmission dynamics, and the impacts of agricultural practices on rhizobia populations. She studies diverse systems, including Medicago-Sinorhizobium, soybean-Bradyrhizobium, and invasive legume-rhizobium interactions. Recent publications (2020–2025) highlight studies on endophyte impacts on soybean yield, rhizobia diversity under conventional farming, and genomic analyses of symbiotic coevolution. Her work integrates molecular biology, quantitative genetics, and ecology. Grants & Collaborations: Lead PI on a $12.5M NSF Biology Integration Institute (Genomics and Eco-evolution of Multi-scale Symbiosis). Her team includes collaborations with institutions like Indiana University and the University of Chicago. Labs & Teams: Heath Lab focuses on symbiosis research, with active projects on microbiome dynamics, plasmid-host coevolution, and community outreach (e.g., Boys and Girls Club collaborations). Recent lab highlights include student graduations (e.g., Ivan Sosa Marquez, Chase) and awards like the John R. Laughnan Award in Plant Biology.

• Microbiome and Microbial Communities
• Evolutionary Genetics
• Symbiosis and Mutualism Evolution
• +3 more

Dr. Michael Baym is an Associate Professor of Biomedical Informatics at Harvard Medical School with affiliate appointments in Microbiology and the Laboratory of Systems Pharmacology, and as an Associate Member of the Broad Institute. He leads the Baym Lab, which studies microbial evolutionary genomics and antibiotic resistance through a hybrid of experimental, computational, and theoretical approaches. His research focuses on: Antibiotic Resistance Evolution and practical interventions Mobile Genetic Elements (plasmids, phages, transposons) Computational Genomic Algorithms for big data analysis Synthetic Biology tools and technologies Key recent publications explore phage discovery systems , phylogenetic compression of microbial genomes, and RNA-guided gene drives in plasmids. His work is supported by multiple NIH/NIGMS and NSF grants including a MIRA award. Scientific honors include: Packard Fellowship (2018) Pew Biomedical Scholarship (2020) Sloan Research Fellowship (2020) A. Clifford Barger Excellence in Mentoring Award (2021) SSQBio Mentorship Award (2022) The lab actively trains PhD students and postdoctoral fellows with alumni occupying academic and industry positions globally. Current team members include researchers from interdisciplinary backgrounds working at the intersection of experiment, computation, and theory .

• Microbial Evolutionary Genomics
• Antibiotic Resistance
• Computational Biology
• +7 more

Istvan Mody is a Professor at the University of California, Los Angeles (UCLA) with appointments in the Department of Neurology and Department of Physiology . His research focuses on synaptic signaling in health and disease, including mechanisms of GABAergic transmission, calcium homeostasis, and their roles in neurological disorders such as epilepsy, Alzheimer's disease, Huntington's disease, stress, alcoholism, and postpartum depression. He utilizes advanced techniques like patch-clamp electrophysiology, neuroanatomical and immunohistochemical methods, and molecular biology in animal models and human brain tissue . Research Interests: Dr. Mody investigates the physiology, pharmacology, and pathology of synaptic transmission and extrasynaptic receptor activation , with a particular emphasis on GABA(A) receptors and their subunit-specific modulation. His work explores how disruptions in excitation-inhibition balance contribute to neurological diseases, including mechanisms of tonic inhibition , calcium signaling , and neurosteroid interactions . He also studies the effects of chronic stress and hormonal fluctuations on neural excitability and behavior. Publications Trends: Recent studies highlight his work on gamma oscillations in Alzheimer's models, microglial dynamics , and rehabilitation strategies for stroke. His lab develops optical tools like dqGEVI for neuronal activity monitoring and investigates human brain organoids to model network dysfunction in epilepsy and intellectual disability. Laboratory Location: 635 Charles Young Dr S, Los Angeles, CA 90095, United States.

• Neuroscience
• Neurology
• Pharmacology
• +12 more

Jeremy Wang, PhD is an Assistant Professor in the Department of Genetics at the UNC School of Medicine . His research focuses on applying high-performance computational methods and machine learning to analyze high-throughput sequence data using long-read technologies (e.g., Oxford Nanopore) to advance precision personalized medicine . Key disease areas include Inflammatory Bowel Diseases (IBD) Respiratory Infectious Diseases His lab specializes in microbiome analysis , host-pathogen interactions , and computational genomics , working with collaborators in clinical, translational, and computational domains. His publications demonstrate expertise in long-read sequencing applications for Pediatric cancer classification SARS-CoV-2 genomic epidemiology Microbiome spatiotemporal dynamics Murine disease models Drosophilid genome assemblies Metagenomic bias analysis Collaborations span UNC and global institutions, with current work extending to clinical laboratory partnerships for pathogen sequencing and oral microbiome sampling methodology.

• Computational Biology
• Genomics
• Microbiome Research
• +7 more

Maizie Zhou is an Assistant Professor in Biomedical Engineering and Computer Science at Vanderbilt University’s School of Engineering. She holds dual PhDs in Computer Science (Stanford University) and Neuroscience (Wake Forest School of Medicine), with additional degrees from Wake Forest University and Huazhong University of Science and Technology. Her research focuses on computational genomics, bioinformatics, and machine learning applied to problems in cancer genomics, single-cell and spatial transcriptomics, and computational neuroscience. She leads the Zhou Lab, which develops algorithms for structural variant detection, neural circuit analysis, and integrative omics approaches. Recent work includes tools like VolcanoSV and stDyer, and she has received grants from NIH, Vanderbilt Brain Institute, and industry partnerships. Key achievements include VUSE Best Paper Awards, Global Engagement Travel Grants, and mentoring students in prestigious programs like the Provost’s Pathbreaking Discovery Award. Her lab also explores the neural underpinnings of cognitive maturation in primates, combining computational and experimental neuroscience. Education: PhDs in Computer Science (Stanford) and Neuroscience (Wake Forest), MS (Computer Science, Wake Forest), BS (Biotechnology, Huazhong). Research interests span computational genomics (e.g., structural variant detection, haplotype phasing), spatial transcriptomics (clustering, integration), and computational neuroscience (neural circuit dynamics, prefrontal cortex plasticity). Her lab’s tools address challenges in precision medicine, cancer genomics, and understanding adolescent brain development. Recent projects include NIH-funded work on spatial transcriptomics and collaborations with Dr. Meltzer’s lab on cancer genomics. Publications highlight advancements in bioinformatics tools and neural mechanisms, with trends toward multi-omics integration and algorithmic innovation in genomics. Awards include the Global Engagement Travel Grant and CCSB Accelerator Fund. Students under her mentorship have excelled in qualifying exams and travel grants, reflecting her impactful training program.

• Computational Genomics
• Bioinformatics
• Computational Neuroscience
• +6 more

Alicia Che is an Assistant Professor of Psychiatry at Yale University School of Medicine and serves as Director of Graduate Admissions for the Interdepartmental Neuroscience Program. She joined the Yale Department of Psychiatry in 2021 after completing her postdoctoral fellowship with Dr. Natalia De Marco García at Weill Cornell Medical College and Dr. Gord Fishell at NYU. Her research is conducted through the Che Lab at Yale, where she investigates how early life experiences impact brain circuit assembly and mature function in models of psychiatric illness. Yale School of Medicine, Department of Psychiatry Interdepartmental Neuroscience Program Center for Brain & Mind Health Division of Molecular Psychiatry Wu Tsai Institute Yale Center for the Science of Cannabis and Cannabinoids Dr. Che earned her Ph.D. in Physiology and Neurobiology from the University of Connecticut in 2014, where she worked in the laboratory of Dr. Joseph LoTurco. She received her B.S. with triple majors in Biology, Physics, and Physical Chemistry from Pacific Lutheran University in Washington state in 2009. Her research focuses on understanding developmental trajectories following early life experiences to develop diagnostics and early interventions for psychiatric illnesses. Dr. Che's research examines how sensory inputs, social bonding, stress, and substance exposure impact brain development. She employs a multi-dimensional approach to assess transcriptional, circuit, neuronal activity, and behavioral changes across the entire developmental timeline. Her lab currently focuses on four specific areas: the role of oxytocin in social behavior development, circuit dysfunction in PTSD, early-life cannabinoid exposure effects, and the impact of early life stress on development and adulthood. She utilizes advanced techniques including mouse genetics, slice electrophysiology, and longitudinal in vivo 2-photon imaging on behaving animals. Her most recent publications demonstrate significant contributions to understanding neural circuit development, PTSD mechanisms, and the effects of early life experiences on brain function. Her work spans from molecular neuroscience to behavioral outcomes, with publications in top journals including Nature, Neuron, and Nature Communications. Her research has revealed important insights into how translaminar neuronal activity strengthens cortical columns, how oxytocin facilitates social touch development, and how PTSD affects brain transcriptomics. NARSAD Young Investigator Award (2020) K99/R00 Pathway to Independence Award from NINDS (2019) Dr. Che's work has significant implications for understanding and treating neurodevelopmental disorders, PTSD, and the consequences of early life experiences on mental health. She collaborates extensively with researchers across Yale and beyond, with frequent co-authorship with colleagues including Lin Lin, Alex Kwan, and Christopher Pittenger. Her research program bridges basic neuroscience with clinical applications, aiming to translate findings into potential interventions for psychiatric conditions.

• Neuroscience
• Developmental Neuroscience
• Behavioral Neuroscience
• +5 more

Nathan G. Swenson is a Professor in the Department of Biological Sciences at the University of Notre Dame and serves as the Gillen Director of the Environmental Research Center (UNDERC). He has held prior academic positions at the University of Maryland and Michigan State University, advancing from Assistant to full Professor. His research integrates genomics, ecology, and evolutionary biology to understand forest biodiversity and dynamics. Research Interests: Ecology and Environmental Biology Evolutionary Biology Genetics and Genomics Global Change Biology Forest Ecology Functional and Phylogenetic Ecology Tree Physiology and Demography His research focuses on leveraging intra- and interspecific variation in tree performance to predict forest biodiversity patterns. He employs integrative approaches from genomes to forest canopies and utilizes large-scale global datasets. Recent publications emphasize intraspecific trait variation, transcriptomic responses to drought, ecological forecasting, and functional group dynamics in tropical and temperate forests. Scientific Awards: Winner of 2017 British Ecological Society John Harper Prize (awarded to J. Zambrano; Swenson was senior author) Advising and Grants: Dr. Swenson has mentored numerous researchers, including M.N. Umana, S.J. Worthy, and J. Yang, who frequently co-author high-impact papers. His lab receives substantial research funding, evident from large collaborative projects and participation in global networks like ForestGEO and the TRY plant trait database. He has secured support for long-term ecological research, genomic studies, and international fieldwork. Labs and Teams: He leads the Swenson Lab, which conducts research on woody plant ecology in dynamic environments. The lab emphasizes community transcriptomics, functional trait analysis, and large-scale ecological modeling. It collaborates widely across institutions and is involved in major initiatives such as ForestGEO and NEON.

• Ecology and Environmental Biology
• Evolutionary Biology
• Genetics and Genomics
• +10 more

Betsy Foxman serves as the Hunein F. and Hilda Maassab Professor of Epidemiology at the University of Michigan School of Public Health. She directs three major initiatives: the Center for Molecular and Clinical Epidemiology of Infectious Diseases, the Integrated Training in Microbial Systems program, and the Certificate in Healthcare Infection Prevention & Control. Her academic leadership spans decades with continuous research contributions. Dr. Foxman earned her PhD and MSPH from UCLA (1983, 1980) and BS from UC Berkeley (1977). Her research centers on infectious disease transmission, microbiome ecology, antibiotic resistance, and wastewater surveillance . Key projects include analyzing the oral microbiome in dental caries using genomic methods, studying nose/throat microbiome associations with respiratory infections in nursing facilities, and developing wastewater monitoring for antibiotic-resistant pathogens. Her work integrates next-generation sequencing with epidemiological analysis to identify novel interventions. Publication trends reveal consistent focus on microbiome-pathogen interactions across multiple body sites (oral, vaginal, gut, respiratory). Recent articles demonstrate methodological innovation in wastewater epidemiology (2024 Norovirus GII monitoring) and clinical applications like predicting vancomycin-resistant enterococci contamination (2023 Lancet study). Her research bridges molecular microbiology with population health, emphasizing translational potential for diagnostics and public health interventions. Fellow of the Infectious Disease Society of America Fellow of the American College of Epidemiology Fellow of the American Academy of Microbiology Dr. Foxman's advising portfolio includes numerous NIH-funded projects on microbiome dynamics and infection control. Her leadership in the Center for Molecular and Clinical Epidemiology drives collaborative research across departments. Current initiatives focus on wastewater surveillance standardization and microbiome-based diagnostics for infection prevention. She maintains active laboratories for genomic analysis of microbial communities and clinical sample processing.

• Infectious Disease Epidemiology
• Human Microbiome Research
• Antibiotic Resistance
• +5 more

Lailiang Cheng is a Professor in the Horticulture Section of Cornell University's School of Integrative Plant Science, specializing in the physiological processes of deciduous fruit crops (particularly apple). His research focuses on sugar/malate metabolism, mineral nutrition, and environmental stress responses to improve orchard productivity and fruit quality. He integrates physiological, biochemical, and molecular approaches to study sorbitol signaling and nutrient management in high-density orchards. Education: Doctorate, Oregon State University (1999) Master of Science, Shandong Agricultural University (1989) Bachelor of Science, Shandong Agricultural University (1984) Research Focus: Cheng's work investigates carbon partitioning, malate accumulation, and nutrient transport dynamics in apple trees under abiotic stresses. His extension program delivers nutrient management strategies to the apple industry, while his teaching emphasizes analytical techniques (PLSCI 6170) and crop nutrition principles (PLSCI 4551/6551). Publication Analysis: Recent articles (2021-2025) reveal dominant themes in molecular regulation of fruit acidity, transporter biology, stress-responsive transcription factors, and omics-assisted breeding. Over 70% of publications involve collaborative work on apple genomics, with consistent emphasis on translating basic research into orchard management solutions. Awards & Recognition: No scientific awards mentioned in source materials. Academic Contributions: Advises graduate students in Horticulture; research supported by Cornell University Agricultural Experiment Station. Collaborates extensively with pomology breeders, extension specialists, and molecular biologists globally.

• Plant Physiology
• Fruit Crop Nutrition
• Sugar Metabolism
• +5 more

Pilar Pérez Romero is an Associate Professor in the Department of Biological Sciences at the University of Notre Dame, where she leads research on human cytomegalovirus (CMV) and host immune interactions. She has previously held academic positions at the National Centre for Microbiology in Madrid and the Biomedical Institute of Seville, Spain. Her research interests include: Virology and molecular mechanisms of CMV infection Virus-host interactions and immune evasion CMV-specific T-cell and neutralizing antibody responses Immunotherapy and vaccine design for CMV Applications in solid organ transplant recipients and congenital infection Her recent publications show a strong focus on CMV immunopathogenesis, with increasing emphasis on translational applications such as monoclonal antibody therapies, adoptive T-cell transfer, and vaccine development. She frequently employs transcriptomic and proteomic methods and collaborates on clinical studies involving transplant patients. Her scientific contributions include: Characterization of CMV antigens inducing protective immunity Identification of novel viral gene products involved in immune regulation Development of methods for CMV gene deletion and functional studies Contributions to clinical guidelines for CMV management in transplantation Dr. Pérez Romero advises research students and collaborates with multidisciplinary teams, including immunologists, virologists, and clinicians. Her work is supported by institutional and collaborative research funding, with potential applications in antiviral therapies and vaccinology. She leads a research laboratory focused on viral immunology and pathogenesis at Notre Dame.

• Virology
• Immunology
• Infectious Diseases
• +12 more

Johanna Kowalko serves as an Associate Professor in the Department of Biological Sciences at Lehigh University, where she maintains an active research program focused on evolutionary and behavioral genetics. Her laboratory investigates the genetic and neural mechanisms underlying behavioral diversity using Astyanax mexicanus (blind cavefish) as a model system. The cavefish model provides unique opportunities to study convergent evolution through independently colonized cave populations. Her primary research interests center on four interconnected themes: (1) How natural genetic variation alters developmental processes to produce phenotypic change, particularly eye regression in cavefish; (2) The role of pleiotropy in behavioral evolution, especially the relationship between albinism and sleep loss; (3) The evolution of behavioral plasticity in response to environmental conditions like nutrient availability; and (4) Evolutionary approaches to identify genetic architecture regulating social behavior, comparing highly social surface fish with cave-adapted populations showing reduced social behaviors. Her work bridges developmental biology, neuroscience, and evolutionary genetics to understand how behaviors evolve. Dr. Kowalko's recent publications demonstrate significant contributions to understanding convergent evolution of cave adaptations, with particular emphasis on sleep regulation, circadian rhythms, and sensory system modifications. Her research has revealed how the oca2 gene pleiotropically influences both albinism and sleep loss in cavefish populations. Her scientific recognition includes being featured as an In the Spotlight – Early Career Researcher in the Journal of Experimental Zoology B. She has contributed to major collaborative efforts including the chromosome-level genome assembly of Astyanax mexicanus . Dr. Kowalko actively develops genetic and experimental methodologies for cavefish research, including CRISPR-based genome editing techniques. Her laboratory examines both laboratory and wild populations to understand the environmental contexts driving evolutionary changes in behavior and morphology. Current field research focuses on defining sleep, feeding, and social behaviors in natural cave environments to identify selective pressures shaping these adaptations.

• Evolutionary Biology
• Behavioral Genetics
• Neural Development
• +3 more

Guillaume Chanfreau is a Professor in the Department of Chemistry and Biochemistry within the College of Letters and Science at the University of California Los Angeles (UCLA). His research focuses on fundamental mechanisms of RNA metabolism, with particular emphasis on RNA splicing, decay pathways, and ribonuclease functions. His work spans molecular biology, biochemistry, and genetics, utilizing yeast as a primary model organism to investigate conserved RNA processing mechanisms. Professor Chanfreau's research interests center on understanding how RNA processing pathways regulate gene expression. His work examines transcription termination, RNA splicing fidelity, RNA decay mechanisms, and the role of ribonucleases in cellular RNA homeostasis. He investigates how these processes are interconnected and how they respond to cellular stress conditions. His laboratory has made significant contributions to understanding how RNA quality control mechanisms prevent the accumulation of aberrant transcripts and maintain cellular health. Analysis of Chanfreau's recent publications (2020-2025) reveals a strong focus on RNA splicing mechanisms, RNA decay pathways, and ribonuclease functions. His work frequently employs yeast genetics combined with advanced RNA sequencing techniques. A notable trend is the increasing use of long-read sequencing technologies to analyze RNA isoforms and decay intermediates. His research consistently bridges fundamental molecular mechanisms with potential implications for understanding human diseases related to RNA processing defects. Professor Chanfreau has been continuously funded by the National Institutes of Health, with his current grant R35GM130370 (2019-2023) titled 'The Control of Gene Expression by Eukaryotic Ribonucleases' and previous long-term funding through R01GM061518 (2000-2019). His research program has supported numerous graduate students and postdoctoral researchers who have contributed to his extensive publication record spanning over two decades.

• RNA metabolism
• RNA splicing
• RNA decay pathways
• +5 more